Daniel H. Solomon
Daniel H. Solomon publishes mostly in Rheumatology, Surgery and Nephrology, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Bone health and osteoporosis research.
- World rank
- #33,271 of 7,710,434 ranked researchers
- Rank in United States
- #12,655 of 1,627,098
- Works
- 796
- Citations
- 53k
- Citations per work
- 66.7
What does Daniel H. Solomon research?
Daniel H. Solomon's work is mostly in Medicine (45%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else40951.4%
- Health Sciences36145.3%
- Medicine36145.3%
- Life Sciences263.3%
- 1Rheumatology26% of their works
- 2Surgery6% of their works
- 3Nephrology5% of their works
- 4Orthopedics and Sports Medicine5% of their works
- 5Endocrinology, Diabetes and Metabolism3% of their works
- 6Immunology3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Bone health and osteoporosis research
- Gout, Hyperuricemia, Uric Acid
- Systemic Lupus Erythematosus Research
- Medication Adherence and Compliance
- Inflammatory mediators and NSAID effects
- Autoimmune and Inflammatory Disorders Research
Which keywords describe Daniel H. Solomon's research?
The keywords of their largest research topics: Cardiovascular Risk, Inflammation, Autoantibodies, Biological Therapy, Rheumatoid Arthritis, Ankylosing Spondylitis, Spondyloarthritis and Bone Mineral Density.
- Hemophagocytic Lymphohistiocytosis
- Cancer
- Medication Adherence
- Antiphospholipid Syndrome
- Hyperuricemia
- Bone Mineral Density
- Ankylosing Spondylitis
- Biological Therapy
- Inflammation
- Cardiovascular Risk
- Autoantibodies
- Rheumatoid Arthritis
- Spondyloarthritis
- Fractures
- Uric Acid
- Systemic Lupus Erythematosus
- Treatment Adherence
- Cyclooxygenase-2 Inhibitors
- Juvenile Idiopathic Arthritis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cardiovascular Risk4943 topics
- Inflammation4943 topics
- Autoantibodies4352 topics
- Biological Therapy3591 topic
- Rheumatoid Arthritis3591 topic
- Ankylosing Spondylitis921 topic
- Spondyloarthritis921 topic
- Bone Mineral Density891 topic
- Fractures891 topic
- Hyperuricemia861 topic
- Uric Acid861 topic
- Antiphospholipid Syndrome761 topic
- Systemic Lupus Erythematosus761 topic
- Medication Adherence571 topic
- Treatment Adherence571 topic
- Cancer491 topic
- Cyclooxygenase-2 Inhibitors491 topic
- Hemophagocytic Lymphohistiocytosis401 topic
- Juvenile Idiopathic Arthritis401 topic
Where does Daniel H. Solomon work?
Daniel H. Solomon's main affiliation in the publication record is Brigham and Women's Hospital, United States.
How many publications and citations does Daniel H. Solomon have?
OpenAlex counts 796 works and 53,119 citations for Daniel H. Solomon, an h-index of 115, ranking #33,271 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel H. Solomon. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.